Copyright © 2019 Takeda Pharmaceutical Company Limited. All rights reserved. All trademarks are the property of their respective owners

VV-MEDCOM-12829 01/2019

Shire is now part of TakedaThis meeting is initiated, funded and organized by Takeda and is not a�liated with The European Association for Haemophilia and Allied Disorders 12th annual congress

Takeda invites you and your colleagues to attend a scientific symposium to learn and engage in dialogue as the Faculty speakers discuss:

PERSONALIZATIONRE-VISITED: CAN WE AIM HIGHER?WEDNESDAY 6TH FEBRUARY 2019, 11:30 – 12:45FORUM HALL, PRAGUE CONGRESS CENTRE, PRAGUE

Jan Blatný (CZ)& Wol�ard Erdlenbruch (CH)

Advancing to the next level of hemophilia A care: individualized treatment and interactive technology Christoph Königs (DE)

The paradigm shift in VWD: a review of personalized treatment scenarios

Case in point: individualized care for patients with hemophilia and inhibitors

Panel Discussion

Frank Leebeek (NL)

Gili Kenet (IL)

All Faculty (Chair: Jan Blatný)

SESSION TITLE SPEAKER

Welcome & Introductions